Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1α

Cited by (999)

Items 301–400 of 999

1. D-2-Hydroxyglutarate in Glioma Biology
   Fu-Ju Chou, Yang Liu, Fengchao Lang, Chunzhang Yang · 2021 · Cells
2. Molecular Diagnostics of Gliomas
   Marina N. Nikiforova, Ronald L. Hamilton · 2011 · Archives of Pathology & Laboratory Medicine
3. Mutant IDH1-Driven Cellular Transformation Increases RAD51-Mediated Homologous Recombination and Temozolomide Resistance
   Shigeo Ohba, Joydeep Mukherjee, Wendy L. See, Russell O. Pieper · 2014 · Cancer Research
4. MGMT CpG island is invariably methylated in adult astrocytic and oligodendroglial tumors with IDH1 or IDH2 mutations
   Shani A. Mulholland, Danita M. Pearson, Rifat Hamoudi, Deborah S. Malley, Caroline M. Smith, Jamie M. J. Weaver, David Jones, Sylvia Kocialkowski, L. Magnus Bäcklund, Vincent Peter Collins et al. · 2011 · International Journal of Cancer
5. Non-enzymatic chemistry enables 2-hydroxyglutarate-mediated activation of 2-oxoglutarate oxygenases
   Tarhonskaya, Hanna, Rydzik, Anna M., Leung, Ivanhoe K. H., Loik, Nikita D., Chan, Mun Chiang, Kawamura, Akane, McCullagh, James S. O., Claridge, Timothy D. W., Flashman, Emily, Schofield, Christopher J. · 2014 · Nature Communications
6. Machine learning and radiomic phenotyping of lower grade gliomas: improving survival prediction
   Yoon Seong Choi, Sung Soo Ahn, Jong Hee Chang, Seok‐Gu Kang, Eui Hyun Kim, Se Hoon Kim, Rajan Jain, Seung‐Koo Lee · 2020 · European Radiology
7. Update on Targets and Novel Treatment Options for High-Grade Osteosarcoma and Chondrosarcoma
   Jolieke G. van Oosterwijk, Jakob Anninga, Hans A. J. Gelderblom, Anne‐Marie Cleton-Jansen, Judith V.M.G. Bovée · 2013 · Hematology/Oncology Clinics of North America
8. Targeting apoptosis pathways in glioblastoma
   Günter Eisele, Michael Weller · 2011 · Cancer Letters
9. Molecular signatures classify astrocytic gliomas by IDH1 mutation status
   Grischa Toedt, Sebastian Barbus, Marietta Wolter, Jörg Felsberg, Björn Tews, Frédéric Blond, Michael Sabel, Stefanie Hofmann, Natália Becker, Christian Johannes Hartmann et al. · 2010 · International Journal of Cancer
10. Isocitrate dehydrogenase (IDH), succinate dehydrogenase (SDH), fumarate hydratase (FH): three players for one phenotype in cancer?
    Giulio Laurenti, Daniel A. Tennant · 2016 · Biochemical Society Transactions
11. 2-HG Inhibits Necroptosis by Stimulating DNMT1-Dependent Hypermethylation of the RIP3 Promoter
    Yang, Zhentao, Jiang, Bin, Wang, Yan, Ni, Hengxiao, Zhang, Jia, Xia, Jinmei, Shi, Minggang, Hung, Li-Man, Ruan, Jingsong, Mak, Tak Wah et al. · 2017 · Cell Reports
12. Detection of IDH1 and IDH2 Mutations by Fluorescence Melting Curve Analysis as a Diagnostic Tool for Brain Biopsies
    Craig Horbinski, Lindsey M. Kelly, Yuri E. Nikiforov, Mary Beth Durso, Marina N. Nikiforova · 2010 · Journal of Molecular Diagnostics
13. Mutations in the Isocitrate Dehydrogenase Genes IDH1 and IDH2 in Tumors
    Frank G. Schaap, Pim J. French, Judith V.M.G. Bovée · 2012 · Advances in Anatomic Pathology
14. Biology, genetics and imaging of glial cell tumours
    Carol A Walker, Atik Baborie, Daniel A. Crooks, Simone Wilkins, Michael D. Jenkinson · 2011 · British Journal of Radiology
15. Trial Watch: Immunotherapy plus radiation therapy for oncological indications
    Erika Vacchelli, Norma Bloy, Fernando Aranda, Aitziber Buqué, Isabelle Cremer, Sandra Demaria, Alexander M.M. Eggermont, Silvia Chiara Formenti, Wolf H. Fridman, Jitka Palich Fucikova et al. · 2016 · OncoImmunology
16. Expression Profile Analysis Identifies a Novel Five-Gene Signature to Improve Prognosis Prediction of Glioblastoma
    Wen Yin, Guihua Tang, Quanwei Zhou, Yudong Cao, Haixia Li, Xianyong Fu, Zhaoping Wu, Xingjun Jiang · 2019 · Frontiers in Genetics
17. OH, the Places You’ll Go! Hydroxylation, Gene Expression, and Cancer
    Athanasios Ploumakis, Mathew L. Coleman · 2015 · Molecular Cell
18. TET2 promoter methylation in low-grade diffuse gliomas lacking IDH1/2 mutations: Figure 1
    Young-Ho Kim, Daniela Pierscianek, Michel Guy André Mittelbronn, Anne Vital, Luigi Mariani, Martin Hasselblatt, Hiroko Ohgaki · 2011 · Journal of Clinical Pathology
19. Synthetic lethal strategies for the development of cancer therapeutics
    Natalie Y.L. Ngoi, David Gallo, Carlos Torrado, Mirella Nardo, Daniel Durocher, Timothy Anthony Yap · 2024 · Nature Reviews Clinical Oncology
20. IDH1/2 mutation is a prognostic marker for survival and predicts response to chemotherapy for grade II gliomas concomitantly treated with radiation therapy
    Yoshiko Okita, Yoshitaka Narita, Yasuji Miyakita, Makoto Ohno, Yuko Matsushita, Shintaro Fukushima, Minako Sumi, Koichi Ichimura, Takamasa Kayama, Soichiro Shibui · 2012 · International Journal of Oncology
21. Metabolism and the leukemic stem cell
    Omar Ibrahim Abdel-Wahab, Ross L. Levine · 2010 · The Journal of Experimental Medicine
22. Metabolic Mechanisms of Epigenetic Regulation
    Jordan L. Meier · 2013 · ACS Chemical Biology
23. Integrated Metabolomics and Lipidomics Analyses Reveal Metabolic Reprogramming in Human Glioma with IDH1 Mutation
    Lina Zhou, Zhichao Wang, Chunxiu Hu, Chaoqi Zhang, Petia Kovatcheva‐Datchary, Di Yu, Shasha Liu, Feifei Ren, Xiaolin Wang, Yanli Li et al. · 2018 · Journal of Proteome Research
24. Selective inhibition of mutant IDH1 by DS-1001b ameliorates aberrant histone modifications and impairs tumor activity in chondrosarcoma
    Makoto Nakagawa, Fumihiko Nakatani, Hironori Matsunaga, Takahiko Seki, Makoto Endo, Yoko Ogawara, Yukino Machida, Takuo Katsumoto, Kazutsune Yamagata, Ayuna Hattori et al. · 2019 · Oncogene
25. The Tricarboxylic Acid Cycle at the Crossroad Between Cancer and Immunity
    Alessandra Scagliola, Francesco Mainini, Simone Cardaci · 2019 · Antioxidants and Redox Signaling
26. Isocitrate dehydrogenase mutations in leukemia
    Anna Sophia McKenney, Ross L. Levine · 2013 · Journal of Clinical Investigation
27. IDH1 and IDH2: Not Your Typical Oncogenes
    Zachary J. Reitman, Donald Williams Parsons, Hai Yan · 2010 · Cancer Cell
28. Tumor Metabolism of Malignant Gliomas
    Peng Ru, Terence Marques Williams, Arnab Chakravarti, Deliang Guo · 2013 · Cancers
29. Androgen receptor reverses the oncometabolite R-2-hydroxyglutarate-induced prostate cancer cell invasion via suppressing the circRNA-51217/miRNA-646/TGFβ1/p-Smad2/3 signaling
    Hua Xu, Yin Sun, Bosen You, Chi‐Ping Huang, Dingwei Ye, Chawnshang Chang · 2019 · Cancer Letters
30. R132C IDH1 Mutations Are Found in Spindle Cell Hemangiomas and Not in Other Vascular Tumors or Malformations
    Kyle C. Kurek, Twinkal C. Pansuriya, Maayke A.J.H. van Ruler, Brendy van den Akker, Valerie L. Luks, Sofie Verbeke, Harry P. Kozakewich, Raf Sciot, Dina Chelouche Lev, Alexander J. Lazar et al. · 2013 · American Journal Of Pathology
31. Molecular Biology of Glioma
    Tomotoshi Marumoto, Hideyuki Saya · 2012 · Advances in experimental medicine and biology
32. Acetoacetate Accelerates Muscle Regeneration and Ameliorates Muscular Dystrophy in Mice
    Xiaoting Zou, Jiao Meng, Li Li, Wanhong Han, Changyin Li, Ran Zhong, Xuexia Miao, Jun Chao Cai, Yong Zhang, Dahai Zhu · 2015 · Journal of Biological Chemistry
33. Prospective of curcumin, a pleiotropic signalling molecule from Curcuma longa in the treatment of Glioblastoma
    Pratibha Mehta Luthra, Neetika Lal · 2015 · European Journal of Medicinal Chemistry
34. Biology of IDH mutant cholangiocarcinoma
    Meng‐Ju Wu, Lei Shi, Joshua Merritt, Andrew Xiuxuan Zhu, Nabeel M. Bardeesy · 2022 · Hepatology
35. Mutant IDH1 Dysregulates the Differentiation of Mesenchymal Stem Cells in Association with Gene-Specific Histone Modifications to Cartilage- and Bone-Related Genes
    Yonghui Jin, Hassan Elalaf, Makoto Watanabe, Sakura Tamaki, Sho Hineno, Kazuhito Matsunaga, Knut Woltjen, Yukiko Kobayashi, Sanae Nagata, Makoto Ikeya et al. · 2015 · PLoS ONE
36. R132H-mutation of isocitrate dehydrogenase-1 is not sufficient for HIF-1α upregulation in adult glioma
    Susan C. Williams, Matthias A. Karajannis, Luis A. Chiriboga, John G. Golfinos, Andreas von Deimling, David Zagzag · 2010 · Acta Neuropathologica
37. IDH Mutations in Human Glioma
    Won Bae Kim, Linda M. Liau · 2012 · Neurosurgery Clinics of North America
38. Detection of ATRX and IDH1-R132H immunohistochemistry in the progression of 211 paired gliomas
    Jinquan Cai, Ping Zhu, Chuanbao Zhang, Qingbin Li, Zhiliang Wang, Guanzhang Li, Guangzhi Wang, Pei Yang, Jianlong Li, Bo Ram Han et al. · 2016 · Oncotarget
39. Altered cancer cell metabolism in gliomas with mutant IDH1 or IDH2
    Alexandra Borodovsky, Meghan J. Seltzer, Gregory Joseph Riggins · 2011 · Current Opinion in Oncology
40. Glioblastoma multiforme: a perspective on recent findings in human cancer and mouse models
    Sang Kyun Lim, Sheila R. Alcantara Llaguno, Renée M. McKay, Luis F. Parada · 2011 · BMB Reports
41. Review of metabolic pathways activated in cancer cells as determined through isotopic labeling and network analysis
    Wentao Dong, Mark A. Keibler, Gregory N Stephanopoulos · 2017 · Metabolic Engineering
42. The role of mutant IDH1 and IDH2 inhibitors in the treatment of acute myeloid leukemia
    Samah Nassereddine, Coen Johannes Gerardus Lap, Faysal Haroun, Imad A. Tabbara · 2017 · Annals of Hematology
43. Dysregulated Lipid Synthesis by Oncogenic IDH1 Mutation Is a Targetable Synthetic Lethal Vulnerability
    Danièl Thomas, Manhong Wu, Yusuke Nakauchi, Ming Zheng, Chloe A. L. Thompson-Peach, Kelly SY Lim, Niklas Landberg, Thomas Köhnke, Nirmal Robinson, Satinder Kaur et al. · 2022 · Cancer Discovery
44. Balancing biosynthesis and bioenergetics: metabolic programs in oncogenesis
    Jennifer F. Barger, David R. Plas · 2010 · Endocrine Related Cancer
45. In silico gene expression analysis reveals glycolysis and acetate anaplerosis in IDH1 wild-type glioma and lactate and glutamate anaplerosis in IDH1-mutated glioma
    Mohammed Khurshed, Remco Jurriaan Molenaar, Krissie Lenting, William P. J. Leenders, Cornelis J.F. Van Noorden · 2017 · Oncotarget
46. Stable Isotope Labeling Highlights Enhanced Fatty Acid and Lipid Metabolism in Human Acute Myeloid Leukemia
    Lucille Stuani, Fabien Riols, Pierre Millard, Marie Sabatier, Aurélie Batut, Estelle Saland, Fanny Viars, Laure Tonini, Sonia Zaghdoudi, Laetitia Karine Linares et al. · 2018 · International Journal of Molecular Sciences
47. Isocitrate dehydrogenase variants in cancer — Cellular consequences and therapeutic opportunities
    Shuang Liu, Tom A.D. Cadoux-Hudson, Christopher John Schofield · 2020 · Current Opinion in Chemical Biology
48. The immortalizing and transforming ability of two common human papillomavirus 16 E6 variants with different prevalences in cervical cancer
    Christina Richard, Carita Lannér, Stanislav Naryzhny, Levana Sherman, H Lee, Paul F. Lambert, Ingeborg Zehbe · 2010 · Oncogene
49. Nature's inordinate fondness for metabolic enzymes: why metabolic enzyme loci are so frequently targets of selection
    James H. Marden · 2013 · Molecular Ecology
50. IDH mutation status impact on in vivo hypoxia biomarkers expression: new insights from a clinical, nuclear imaging and immunohistochemical study in 33 glioma patients
    Philippe Métellus, Carole Colin, David Taïeb, Éric Guedj, Isabelle Nanni‐Metellus, A. Maues de Paula, Cecile Colavolpe, Stéphane Fuentes, Henry Dufour, Marylin Barrie et al. · 2011 · Journal of Neuro-Oncology
51. IDH1 Mutations in Gliomas: When an Enzyme Loses Its Grip
    Christian Frezza, Daniel A. Tennant, Eyal Gottlieb · 2010 · Cancer Cell
52. Isocitrate dehydrogenase 1 mutant R132H sensitizes glioma cells to BCNU-induced oxidative stress and cell death
    Isabelle Vanessa Mohrenz, Patrick Antonietti, Stefan Pusch, David Capper, Jörg Balß, Sophia Voigt, Susanne Weißert, Alicia Mukrowsky, Jan Frank, Christian Senft et al. · 2013 · APOPTOSIS
53. EZH2-, CHD4-, and IDH-linked epigenetic perturbation and its association with survival in glioma patients
    Le Zhang, Ying Liu, Mengning Wang, Zhenhai Wu, Na Li, Jinsong Zhang, Chuanwei Yang · 2017 · Journal of Molecular Cell Biology
54. Gene mutations of acute myeloid leukemia in the genome era
    Tomoki Naoe, Hitoshi Kiyoi · 2013 · International Journal of Hematology
55. Identification of Isocitrate Dehydrogenase 1 as a Potential Diagnostic and Prognostic Biomarker for Non-small Cell Lung Cancer by Proteomic Analysis
    Fengwei Tan, Ying Jiang, Nan Sun, Zhaoli Chen, Yongzhuang Lv, Kang Shao, Ning Li, Bin Qiu, Yibo Gao, Baozhong Li et al. · 2011 · Molecular & Cellular Proteomics
56. Glioma Diagnosis: Immunohistochemistry and Beyond
    Erin M Dunbar, Anthony T. Yachnis · 2010 · Advances in Anatomic Pathology
57. Insights into the Pathogenesis and Treatment of Cancer from Inborn Errors of Metabolism
    Ayelet Erez, Oleg A. Shchelochkov, Sharon E. Plon, Fernando Scaglia, Brendan Lee · 2011 · The American Journal of Human Genetics
58. Control of the Antitumor Immune Response by Cancer Metabolism
    Charlotte Domblides, Lydia Lartigue, Benjamin Faustin · 2019 · Cells
59. Can Diffusion Tensor Imaging Noninvasively Detect IDH1 Gene Mutations in Astrogliomas? A Retrospective Study of 112 Cases
    Wenli Tan, Weiyuan Huang, Bo Yin, Ji Xiong, Jinsong Wu, Daoying Geng · 2014 · American Journal of Neuroradiology
60. RBM4 dictates ESCC cell fate switch from cellular senescence to glutamine-addiction survival through inhibiting LKB1-AMPK-axis
    Lei Chen, Wenjing Zhang, Dan Chen, Quan Yang, Siwen Sun, Zhenwei Dai, Zhengzheng Li, Xuemei Liang, Chaoqun Chen, Yuexia Jiao et al. · 2023 · Signal Transduction and Targeted Therapy
61. IDH Mutations in Tumorigenesis and Their Potential Role As Novel Therapeutic Targets
    Daniel Krell, Paul James Mulholland, Adam Enver Frampton, Jonathan Krell, Justin Stebbing, Chiara Bardella · 2013 · Future Oncology
62. Detection of tumor glutamate metabolism in vivo using 13 C magnetic resonance spectroscopy and hyperpolarized [1‐ 13 C]glutamate
    Ferdia Aidan Gallagher, Mikko I. Kettunen, Sam E. Day, De‐En Hu, Magnus G. Karlsson, Anna Gisselsson, Mathilde H. Lerche, Kevin Michael Brindle · 2011 · Magnetic Resonance in Medicine
63. Predictive and prognostic factors for gliomas
    François Ducray, Ahmed Idbaïh, Xiao-Wei Wang, Caroline Cheneau, Marianne Labussière, Marc Sanson · 2011 · Expert Review of Anticancer Therapy
64. Puzzling Patterns of Predisposition
    Patrick J. Pollard, Peter John Ratcliffe · 2009 · Science
65. Normal and cancer cell metabolism: lymphocytes and lymphoma
    Brian James Altman, Chi Van Dang · 2012 · FEBS Journal
66. Dysregulation of metabolic enzymes in tumor and stromal cells: Role in oncogenesis and therapeutic opportunities
    Mohammad Aslam Khan, Haseeb Zubair, Shashi Anand, Sanjeev K. Srivastava, Seema Singh, Ajay Pratap Singh · 2020 · Cancer Letters
67. The role of IDH1 mutated tumour cells in secondary glioblastomas: an evolutionary game theoretical view
    David Basanta, Jacob G. Scott, Russell C. Rockne, Kristin R. Swanson, Alexander R.A. Anderson · 2011 · Physical Biology
68. IDH mutations in Primary Myelofibrosis Predict Leukemic Transformation and Shortened Survival: Clinical Evidence for Leukemogenic Collaboration with JAK2V617F
    Nanna Helen Sulai, Thitina Jimma, Terra L. Lasho, Christy M. Finke, Ryan A. Knudson, Rebecca F. McClure, Animesh Dev Pardanani, Ayalew Tefferi · 2011 · Blood
69. Clinical multiplexed exome sequencing distinguishes adult oligodendroglial neoplasms from astrocytic and mixed lineage gliomas
    Jane B. Cryan, Sam Haidar, Lori A. Ramkissoon, Wenya Linda Bi, David S. Knoff, Nikolaus D. Schultz, Malak Abedalthagafi, Loreal E. Brown, Patrick Yung Wen, David A. Reardon et al. · 2014 · Oncotarget
70. SLC1A1-mediated cellular and mitochondrial influx of R-2-hydroxyglutarate in vascular endothelial cells promotes tumor angiogenesis in IDH1-mutant solid tumors
    Xiaomin Wang, Ziqi Chen, Jun Xu, Shuai Tang, Nan An, Lei Jiang, Yixiang Zhang, Shaoying Zhang, Qingli Zhang, Yanyan Shen et al. · 2022 · Cell Research
71. IDH1 Gene Mutations: A New Paradigm in Glioma Prognosis and Therapy?
    Marianne Labussière, Marc Sanson, Ahmed Idbaïh, Jean‐Yves Delattre · 2010 · The Oncologist
72. A provider's guide to primary myelofibrosis: pathophysiology, diagnosis, and management
    Benjamin Garmezy, Jordan K. Schaefer, Jessica Mercer, Moshe Talpaz · 2020 · Blood Reviews
73. Molecular markers of glioma: an update on recent progress and perspectives
    Kirti Gupta, Pravin Salunke · 2012 · Journal of Cancer Research and Clinical Oncology
74. Molecular mechanisms of isocitrate dehydrogenase 1 (IDH1) mutations identified in tumors: The role of size and hydrophobicity at residue 132 on catalytic efficiency
    Diego Avellaneda Matteo, Adam J. Grunseth, Eric R. Gonzalez, Stacy L. Anselmo, Madison Arza Kennedy, Precious Moman, David A. Scott, An D. Hoang, Christal Dyane Sohl · 2017 · Journal of Biological Chemistry
75. LncRNA‐TP53TG1 Participated in the Stress Response Under Glucose Deprivation in Glioma
    Xin Chen, Yang Gao, Deheng Li, Yiqun Cao, Bin Hao · 2017 · Journal of Cellular Biochemistry
76. The effects of 2-hydroxyglutarate on the tumorigenesis of gliomas
    Cara Reiter–Brennan, Lukas Semmler, Andreas Klein · 2018 · Współczesna Onkologia
77. A Potent Blood–Brain Barrier-Permeable Mutant IDH1 Inhibitor Suppresses the Growth of Glioblastoma with IDH1 Mutation in a Patient-Derived Orthotopic Xenograft Model
    Yukino Machida, Makoto Nakagawa, Hironori Matsunaga, Masayuki Yamaguchi, Yoko Ogawara, Yutaka Shima, Kazutsune Yamagata, Takuo Katsumoto, Ayuna Hattori, Masato Itoh et al. · 2019 · Molecular Cancer Therapeutics
78. From genomics to the clinic: biological and translational insights of mutant IDH1/2 in glioma
    Gavin P. Dunn, Ovidiu C. Andronesi, Daniel P. Cahill · 2013 · Neurosurgical FOCUS
79. Increased mitochondrial activity in a novel IDH1-R132H mutant human oligodendroglioma xenograft model: in situ detection of 2-HG and α-KG
    Anna Catharina Navis, Simone P. Niclou, Fred Fack, Daniel Stieber, Sanne A. M. van Lith, Kiek N. Verrijp, Alan J. Wright, Jonathan Stauber, Bastiaan B.J. Tops, Irene Otte‐Höller et al. · 2013 · Acta Neuropathologica Communications
80. Exploiting metabolic vulnerabilities for personalized therapy in acute myeloid leukemia
    Lucille Stuani, Marie Sabatier, Jean‐Emmanuel Sarry · 2019 · BMC Biology
81. The Acidic Brain—Glycolytic Switch in the Microenvironment of Malignant Glioma
    Anna Maria Reuss, Dominik Groos, Michael Buchfelder, Nicolai E. Savaskan · 2021 · International Journal of Molecular Sciences
82. Isocitrate dehydrogenase status and molecular subclasses of glioma and glioblastoma
    Sameer Agnihotri, Kenneth Aldape, Gelareh Mohammed Zadeh · 2014 · Neurosurgical FOCUS
83. AMP-Activated Protein Kinase α2 in Neutrophils Regulates Vascular Repair via Hypoxia-Inducible Factor-1α and a Network of Proteins Affecting Metabolism and Apoptosis
    Randa Abdel Malik, Nina Zippel, Timo Frömel, Juliana Heidler, Sven Zukunft, Barbara Walzog, Nariman Ansari, Francesco Pampaloni, Susanne Wingert, Michael A. Rieger et al. · 2016 · Circulation Research
84. Glutamine metabolism in Th17/Treg cell fate: applications in Th17 cell-associated diseases
    Guan Yang, Yaoyao Xia, Wenkai Ren · 2020 · Science China Life Sciences
85. Metabolic adaptations in cancers expressing isocitrate dehydrogenase mutations
    Ingvild Comfort Hvinden, Tom A.D. Cadoux-Hudson, Christopher John Schofield, James McCullagh · 2021 · Cell Reports Medicine
86. Molecular Biology in Pediatric High-Grade Glioma: Impact on Prognosis and Treatment
    Daniela Rizzo, Antonio Ruggiero, Maurizio Martini, Valentina Rizzo, Palma Maurizi, Riccardo Riccardi · 2015 · BioMed Research International
87. Prognostic significance of IDH1 mutations in acute myeloid leukemia: a meta-analysis.
    Jianhua Feng, Xiaoping Guo, Yuanyuan Chen, Zhu-Jun Wang, Yu-Ping Cheng, Yongmin Tang · 2012 · PubMed Central
88. Immunohistochemical detection of IDH1 mutation, p53, and internexin as prognostic factors of glial tumors
    Shingo Takano, Yukinari Kato, Tetsuya Yamamoto, Mika Kato Kaneko, Eiichi Ishikawa, Yuta Tsujimoto, Masahide Matsuda, Kei Nakai, Ryo Yanagiya, Shunpei Morita et al. · 2012 · Journal of Neuro-Oncology
89. Detection of IDH1 mutations in gliomatosis cerebri, but only in tumors with additional solid component: evidence for molecular subtypes
    Marcel Seiz, Jochen Tuettenberg, Jochen Meyer, Marco Essig, Kirsten Schmieder, Christian Mawrin, Andreas von Deimling, Christian Johannes Hartmann · 2010 · Acta Neuropathologica
90. Redox regulation of the epigenetic landscape in Cancer: A role for metabolic reprogramming in remodeling the epigenome
    Michael James Hitchler, Frederick E. Domann · 2012 · Free Radical Biology and Medicine
91. Epigenetic aberrations in acute myeloid leukemia: Early key events during leukemogenesis
    Anna Eriksson, Andreas Lennartsson, Sören Lehmann · 2015 · Experimental Hematology
92. Mutant IDH in Gliomas: Role in Cancer and Treatment Options
    Georgios Solomou, Alina Finch, Asim Asghar, Chiara Bardella · 2023 · Cancers
93. Prognostic Value of Isocitrate Dehydrogenase Mutations in Myelodysplastic Syndromes: A Retrospective Cohort Study and Meta-Analysis
    Jie Jin, Chao Hu, Mengxia Yu, Feifei Chen, Li Ye, Xiufeng Yin, Zhengping Zhuang, Hongyan Tong · 2014 · PLoS ONE
94. Extended Ischemia Prevents HIF1α Degradation at Reoxygenation by Impairing Prolyl-hydroxylation
    Anna Serra‐Pérez, Anna Maria Planas, Analía Núñez-O’Mara, Edurne Berra, Judit García‐Villoria, Antònia Ribes, Tomàs Santalucı́a · 2010 · Journal of Biological Chemistry
95. Maffucci syndrome and neoplasms: a case report and review of the literature
    Olga Prokopchuk, Stephanie Andres, Karen Becker, Konstantin Holzapfel, Daniel Hartmann, Helmut Frieß · 2016 · BMC Research Notes
96. Perturbations of cancer cell metabolism by the antidiabetic drug canagliflozin
    David J. Papadopoli, Oro Uchenunu, Ranveer Palia, Nabila Chekkal, Laura Hulea, Ivan Topisirović, Michaël Pollak, Julie St‐Pierre · 2021 · Neoplasia
97. Prognostic significance of alterations in IDH enzyme isoforms in patients with AML treated with high‐dose cytarabine and idarubicin
    Farhad Ravandi, Keyur Pravinchandra Patel, Rajyalakshmi Luthra, Stefan H Faderl, Marina Y Konopleva, Tapan Mahendra Kadia, Mark Brandt, Sherry A. Pierce, Steven Mitchell Kornblau, Michael Andreeff et al. · 2011 · Cancer
98. Mutations of isocitrate dehydrogenase 1 and 2 in intrahepatic cholangiocarcinoma
    Alexandra R. Grassian, Raymond A. Pagliarini, Derek Y. Chiang · 2014 · Current Opinion in Gastroenterology
99. Diffusely infiltrating astrocytomas: pathology, molecular mechanisms and markers
    Koichi Ichimura, Yoshitaka Narita, Cynthia E Hawkins · 2015 · Acta Neuropathologica
100. Metabolic regulation of prostate cancer heterogeneity and plasticity
     Claudia Peitzsch, Ielizaveta Gorodetska, Daria Klusa, Qihui Shi, Tiago C. Alves, Klaus Pantel, Anna Dubrovska · 2020 · Seminars in Cancer Biology